Pulse Biosciences
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 56
- Market Cap
- -
- Introduction
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
NS-PFA Catheter Ablation of Paroxysmal and Persistent Atrial Fibrillation With the Pulse Biosciences CellFX System
- Conditions
- Atrial Fibrillation ParoxysmalCardiac AblationCardiac ArrhythmiaAtrial Fibrillation, Persistent
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 375
- Registration Number
- NCT07018596
- Locations
- 🇧🇪
Clinic Electrophysiology, Heart Center Hasselt, Jessa Hospital, Hasselt, Belgium
🇨🇿Na Homolce Hospital, Prague, Roentgenova, Czechia
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
- Conditions
- Atrial FibrillationMaze ProcedureAFAblation
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT06959121
Evaluation of the CellFX® Nano-Pulsed Field Ablation (PFA) 360 Catheter Endocardial Ablation System for the Treatment of Atrial Fibrillation
- Conditions
- Atrial Fibrillation ParoxysmalCardiac AblationCardiac Arrhythmia
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06696170
- Locations
- 🇨🇿
Na Homolce Hospital, Prague, Roentgenova, Czechia
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
- Conditions
- SurgeryAtrial Fibrillation
- Interventions
- Device: CellFX® nsPFA™ Cardiac Surgery System
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06355063
- Locations
- 🇳🇱
Academic Medical Center, Amsterdam, Netherlands
🇳🇱Maastricht University Medical Center+ (MUMC+), Maastricht, Netherlands
🇳🇱St. Antonius Hospital, Nieuwegein, Netherlands
CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules
- Conditions
- Thyroid Nodule (Benign)
- Interventions
- Device: CellFX® Percutaneous Electrode (PE) System
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06117085
- Locations
- 🇮🇹
Ospedale del Mare | ASLNA1 Centro, Naples, Italy
CellFX Treat & Resect Low-Risk BCC Feasibility Study
- Conditions
- BCC - Basal Cell CarcinomaExcision MarginBCC
- Interventions
- Device: CellFX System
- First Posted Date
- 2021-06-08
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04918381
- Locations
- 🇺🇸
Surgical Dermatology Group, Vestavia Hills, Alabama, United States
🇺🇸Moy-Fincher-Chipps Dermatology, Beverly Hills, California, United States
🇺🇸Palm Harbor Dermatology, Clearwater, Florida, United States
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
- Conditions
- Warts HandWartsVerruca
- Interventions
- Device: CellFX System DeviceDevice: Cryosurgery Liquid Nitrogen Sprayer
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT04738734
- Locations
- 🇺🇸
Investigate MD, Scottsdale, Arizona, United States
🇺🇸Moy-Fincher-Chipps Dermatology, Beverly Hills, California, United States
🇺🇸AboutSkin Dermatology and DermSurgery, Greenwood Village, Colorado, United States
CellFX System for the Treatment of Cutaneous Non-Genital Warts
- Conditions
- WartsWarts HandVerruca
- Interventions
- Device: CellFX Device
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT04554394
- Locations
- 🇺🇸
Investigate MD, LLC, Scottsdale, Arizona, United States
🇺🇸Scripps Clinic Carmel Valley, San Diego, California, United States
🇺🇸Skin Search of Rochester, Inc., Rochester, New York, United States
Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions
- Conditions
- Sebaceous HyperplasiaSkin LesionSkin Abnormalities
- Interventions
- Device: CellFX SystemDevice: Intralesional Electrodesiccation
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04539886
- Locations
- 🇺🇸
Investigate MD, LLC, Scottsdale, Arizona, United States
🇺🇸Zel Skin & Laser Specialists, Edina, Minnesota, United States
🇺🇸Dermatology, Laser & Vein Specialists of the Carolinas, PLLC, Charlotte, North Carolina, United States
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study
- Conditions
- Sebaceous HyperplasiaSkin AbnormalitiesSkin Lesion
- Interventions
- Device: Nano-Pulse Stimulation (NPS)
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- Pulse Biosciences, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT04253418
- Locations
- 🇺🇸
Clear Dermatology & Aesthetics Center / InvestigateMD, Scottsdale, Arizona, United States
🇺🇸Laser and Skin Surgery Center of Northern California, Sacramento, California, United States
🇺🇸AVA MD, Santa Monica, California, United States